✦ LIBER ✦

Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom

✍ Scribed by Leteneux, C.; Claxton, L.; Malcolm, W.A.; Taylor, M.; Rathi, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Budget Impact of Introducing Ranibiz

✍ Malcolm, W.A.; Leteneux, C.; Claxton, L.; Taylor, M.; Rathi, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Bevacizumab for choroidal neovasculariza

✍ Bogomil Voykov; Faik Gelisken; Werner Inhoffen; Michael Voelker; Karl Ulrich Bar 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Cost-Effectiveness of Biologic Therapies

✍ Betts, K.A.; Sundaram, M.; Mughal, F.; Yan, S.Y.; Signorovitch, J.; Wang, K.; Wu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB